| Outcomes of robot-assisted laparoscopic transperitoneal pyeloplasty procedures: A series of 18 patients | Kemal ENER,Serkan ALTINOVA,Abdullah Erdem CANDA,MUHAMMET FUAT ÖZCAN,Erem ASİL,Emre ÜRER,Ali Fuat ATMACA,Ziya AKBULUT | 193–198 |
| Apoptosis in testicular tissue of rats after vasectomy: evaluation of eNOS, iNOS immunoreactivities and the efects of ozone therapy | Serhan ALPCAN,Halil BAŞAR,TOLGA REŞAT AYDOS,Oğuz KUL,ÜÇLER KISA,Murad Mehmet BAŞAR | 199–206 |
| Comparison of patient satisfaction rates for the malleable and two piece-infatable penile prostheses | Hakan KILIÇARSLAN,Yurdaer KAYNAK,KAAN GÖKÇEN,BURHAN COŞKUN,ONUR KAYGISIZ | 207–210 |
| Previous shock-wave lithotripsy treatment does not impact the outcomes of fexible ureterorenoscopy | Emrah YÜRÜK,Murat BİNBAY,Tolga AKMAN,Faruk ÖZGÖR,Yalçın BERBEROĞLU,Ahmet Yaser MÜSLÜMANOĞLU | 211–215 |
| Retrospective evaluation of urological admissions to emergency service of a training and research hospital | Ramazan TOPAKTAŞ,Selçuk ALTIN,CEMİL AYDIN,ALİ AKKOÇ,Yakup YILMAZ | 216–220 |
| Montelukast prevents testes against ischemia-reperfusion injury through suppression of iNOS expression | MESRUR SELÇUK SILAY,Hale TOKLU,Ayşim ÖZAĞARI,Mustafa AYDIN,Şermin TETİK,Göksel ŞENER,Cengiz MİROĞLU,Muammer KENDİRCİ | 221–227 |
| What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future? | Mohamed Ismat ABDULMAJED,EYÜP BURAK SANCAK,Berkan REŞORLU,Gydhia Zuhair AL-CHALABY | 228–232 |
| Pubovaginal sling materials and their outcomes | ÖMER BAYRAK,David OSBORN,William Stuart REYNOLDS,Roger Roman DMOCHOWSKI | 233–239 |
| Laparoscopic pyelolithotomy in a horseshoe kidney | Erkan ÖlÇÜCÜOĞLU,AHMET ÇAMTOSUN,Sait BİÇER,Ahmet Murat BAYRAKTAR | 240–244 |
| An unusual complication of a double-J ureteral stent: Renal parenchymal perforation in a solitary kidney | UMUT GÖNÜLALAN,MURAT AKAND,Eray HASIRCI,TEVFİK MURAT KOŞAN | 245–247 |
| Unusual foreign body in the vesico-urethral; 195 cm liquid pipe |